The Patent Finder

Inhibitex, Inc.

Also on record
Records under this name other than the patents Inhibitex, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.

Back to Inhibitex, Inc.

PatentTitleStatus Expires Confidence
US 8,475,798Monoclonal Antibodies Recognizing a Coagulase-Negative Staphylococcal Protein
Formerly held
In force
 · High confidence
In forceHigh confidence
US 9,351,989Substituted purine nucleosides, phosphoroamidate and phosphorodiamidate derivatives for treatment of viral infections
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 7,615,616Bioinformatic Method for Identifying Surface-Anchored Proteins from Gram-Positive Bacteria and Proteins Obtained Thereby
Term ended
Term ended Apr 27, 2025 · High confidence
Term endedTerm ended Apr 27, 2025High confidence
US 7,850,974Bioinformatic method for identifying surface-anchored proteins from gram-positive bacteria and proteins obtained thereby
Term ended
Term ended Sep 15, 2023 · From the USPTO record
Term endedTerm ended Sep 15, 2023From the USPTO record
US 7,115,264Monoclonal antibodies to the fibronectin binding protein and method of use in treating or preventing infections
Term ended
Term ended Nov 5, 2022 · From the USPTO record
Term endedTerm ended Nov 5, 2022From the USPTO record
US 7,364,738Monoclonal antibodies to the CLFA protein and method of use in treating infections
Term ended
Term ended Oct 31, 2022 · From the USPTO record
Term endedTerm ended Oct 31, 2022From the USPTO record
US 6,841,154Cross-reactive monoclonal and polyclonal antibodies which recognize surface proteins from coagulase-negative staphylococci and Staphylococcus aureus
Formerly held
Term ended
Term ended Jun 17, 2022 · From the USPTO record
Term endedTerm ended Jun 17, 2022From the USPTO record
US 7,968,100Surface proteins from coagulase-negative staphylococci and Staphylococcus aureus that generate cross-reactive monoclonal and polyclonal antibodies
Term ended
Term ended Jun 17, 2022 · From the USPTO record
Term endedTerm ended Jun 17, 2022From the USPTO record
US 6,979,446Monoclonal antibodies to the ClfA protein and method of use in treating or preventing infections
Term ended
Term ended Jan 28, 2022 · From the USPTO record
Term endedTerm ended Jan 28, 2022From the USPTO record
US 7,666,438Multicomponent Vaccines
Formerly held
Term ended
Term ended Sep 12, 2021 · Medium confidence
Term endedTerm ended Sep 12, 2021Medium confidence
10 of 21 patents shown.
Pro members see all 21.
Pro members: see all 21 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited